Aadi Bioscience, Inc. (AADI)
NASDAQ: AADI · Real-Time Price · USD
2.185
-0.025 (-1.13%)
Mar 6, 2025, 12:30 PM EST - Market open
Aadi Bioscience Revenue
Aadi Bioscience had revenue of $7.21M in the quarter ending September 30, 2024, with 21.03% growth. This brings the company's revenue in the last twelve months to $25.07M, up 7.80% year-over-year. In the year 2023, Aadi Bioscience had annual revenue of $24.35M with 60.06% growth.
Revenue (ttm)
$25.07M
Revenue Growth
+7.80%
P/S Ratio
2.38
Revenue / Employee
$281,685
Employees
89
Market Cap
53.85M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 24.35M | 9.14M | 60.06% |
Dec 31, 2022 | 15.22M | 14.10M | 1,258.57% |
Dec 31, 2021 | 1.12M | -13.46M | -92.32% |
Dec 31, 2020 | 14.58M | 13.83M | 1,846.60% |
Dec 31, 2019 | 749.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
AADI News
- 1 day ago - Aadi Bioscience Announces Closing of $100 Million PIPE Financing - PRNewsWire
- 3 days ago - Aadi Bioscience Announces Approval of All Proposals at Special Meeting of Stockholders - PRNewsWire
- 10 days ago - Aadi Bioscience to Present at the TD Cowen 45th Annual Healthcare Conference - PRNewsWire
- 16 days ago - Aadi Bioscience Appoints David Dornan, PhD, as Chief Scientific Officer - PRNewsWire
- 4 weeks ago - Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025 - PRNewsWire
- 2 months ago - Why Is Cancer-Focused Aadi Bioscience Stock Trading Higher On Friday? - Benzinga
- 2 months ago - Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing - PRNewsWire
- 4 months ago - Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update - PRNewsWire